This Stock Just Dropped By 15%: Is It a Buy?
Earnings season can be a great time to review one's investments. This is when corporations often take the opportunity to announce business developments which could change their prospects -- and that's exactly what Sanofi (NASDAQ: SNY) recently did. The France-based pharmaceutical giant shared some important news to investors along with its most recent quarterly update, but the market wasn't very receptive.
Sanofi's stock dropped by more than 15% on the heels of its earnings release although it has since recovered some of these losses. Should investors consider investing in Sanofi while its shares are still down?
Source Fool.com